{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:06:11Z","timestamp":1757624771640,"version":"3.44.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Pathogenesis and Therapy"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.cpt.2023.01.003","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T20:57:34Z","timestamp":1673470654000},"page":"146-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Unusual presentation of gastric cancer during treatment of hairy cell leukemia: Exploring the etiological basis of this rare phenomenon"],"prefix":"10.1016","volume":"1","author":[{"given":"Shahan","family":"Tariq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Ammar","family":"Bin Hamid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazia","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsey","family":"Oleary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristine","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aasim","family":"Sehbai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpt.2023.01.003_bib1","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1080\/10428194.2019.1608536","article-title":"Hairy cell leukemia: present and future directions","volume":"60","author":"Kreitman","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.cpt.2023.01.003_bib2","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1182\/blood-2006-08-042929","article-title":"Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial","volume":"109","author":"Robak","year":"2007","journal-title":"Blood"},{"issue":"Suppl 2","key":"10.1016\/j.cpt.2023.01.003_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/10428194.2011.565093","article-title":"Long-term results for pentostatin and cladribine treatment of hairy cell leukemia","volume":"52","author":"Dearden","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.cpt.2023.01.003_bib4","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1182\/blood.V92.4.1160","article-title":"Second malignancies in patients with hairy cell leukemia in British Columbia: a 20-year experience","volume":"92","author":"Au","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.cpt.2023.01.003_bib5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1200\/JCO.2002.20.3.638","article-title":"Risk of second cancer in patients with hairy cell leukemia: long-term follow-up","volume":"20","author":"Federico","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cpt.2023.01.003_bib6","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1600-0609.2006.00732.x","article-title":"A\u00a0population-based study of hairy cell leukemia in Israel","volume":"77","author":"Paltiel","year":"2006","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.cpt.2023.01.003_bib7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1182\/blood-2013-06-508754","article-title":"Clinical characteristics and long-term outcome of young hairy cell leukemia patients treated with cladribine: a single-institution series","volume":"123","author":"Rosenberg","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.cpt.2023.01.003_bib8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41408-020-0328-z","article-title":"Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up","volume":"10","author":"Jerome","year":"2020","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.cpt.2023.01.003_bib9","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s40265-018-1000-9","article-title":"Moxetumomab pasudotox: first global approval","volume":"78","author":"Dhillon","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.cpt.2023.01.003_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00063030-200923010-00001","article-title":"Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignancies","volume":"23","author":"Kreitman","year":"2009","journal-title":"BioDrugs"},{"key":"10.1016\/j.cpt.2023.01.003_bib11","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3390\/biom10081140","article-title":"Development of recombinant immunotoxins for hairy cell leukemia","volume":"10","author":"Kreitman","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.cpt.2023.01.003_bib12","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood-2017-09-803072","article-title":"Minimal residual hairy cell leukemia eradication with moxetumomab pasudotox: phase 1 results and long-term follow-up","volume":"131","author":"Kreitman","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.cpt.2023.01.003_bib13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00280-019-03875-6","article-title":"Moxetumomab pasudotox-tdfk for relapsed\/refractory hairy cell leukemia: a review of clinical considerations","volume":"84","author":"Nobre","year":"2019","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.cpt.2023.01.003_bib14","first-page":"591","article-title":"Risk factors for gastric cancer: a systematic review","volume":"19","author":"Yusefi","year":"2018","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.cpt.2023.01.003_bib15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1476-4598-12-24","article-title":"Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden","volume":"12","author":"Abubaker","year":"2013","journal-title":"Mol Cancer"}],"container-title":["Cancer Pathogenesis and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949713223000034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949713223000034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T15:25:19Z","timestamp":1757431519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949713223000034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2949713223000034"],"URL":"https:\/\/doi.org\/10.1016\/j.cpt.2023.01.003","relation":{},"ISSN":["2949-7132"],"issn-type":[{"type":"print","value":"2949-7132"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unusual presentation of gastric cancer during treatment of hairy cell leukemia: Exploring the etiological basis of this rare phenomenon","name":"articletitle","label":"Article Title"},{"value":"Cancer Pathogenesis and Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpt.2023.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of Chinese Medical Association (CMA).","name":"copyright","label":"Copyright"}]}}